熱門資訊> 正文
Cellectis任命Adrian Kilcoyne为首席医疗官
2024-08-07 18:20
- Cellectis (NASDAQ:CLLS) said it has appointed Adrian Kilcoyne as its chief medical officer, effective immediately.
- Prior to joining the firm, Kilcoyne was the chief medical officer and head of research and development at Celularity.
More on Cellectis
- Cellectis S.A. (CLLS) Q1 2024 Earnings Call Transcript
- Cellectis: 2 Data Readouts Of Blood Cancer Studies By End Of 2024
風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。